Publications
Detailed Information
Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lim, Soo K. | - |
| dc.contributor.author | Goh, Bak L. | - |
| dc.contributor.author | Visvanathan, Ravindran | - |
| dc.contributor.author | Kim, Su H. | - |
| dc.contributor.author | Jeon, Jin S. | - |
| dc.contributor.author | Kim, Sung G. | - |
| dc.contributor.author | Chang, Jae H. | - |
| dc.contributor.author | Lim, Chun S. | - |
| dc.contributor.author | Morad, Zaki | - |
| dc.date.accessioned | 2022-03-21T04:10:55Z | - |
| dc.date.available | 2022-03-21T04:10:55Z | - |
| dc.date.issued | 2022-01-03 | - |
| dc.identifier.citation | BMC Nephrology. 2022 Jan 03;23(1):14 | - |
| dc.identifier.uri | https://doi.org/10.1186/s12882-021-02651-0 | - |
| dc.identifier.uri | https://hdl.handle.net/10371/177079 | - |
| dc.title | Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure | - |
| dc.language.rfc3066 | en | - |
| dc.rights.holder | The Author(s) | - |
| dc.date.updated | 2022-01-09T04:09:59Z | - |
- Appears in Collections:
- Files in This Item:
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.